1. Introduction {#j_med-2018-0071_s_001}
===============

Vancomycin has been the primary agent used to treat serious MRSA infection for many years. However, the rise of MRSA infection rates and the extensive use of vancomycin have led to the emergence of reduced vancomycin susceptibility. Vancomycin resistant *S. aureus* strains are associated with inefficient vancomycin treatment \[[@j_med-2018-0071_ref_001]\]. Nowadays more and more clinical *S. aureus* strains with reduced vancomycin susceptibility have been reported frequently, including hVISA and VISA \[2-[@j_med-2018-0071_ref_007]\]. In 2008, researchers from peking union medical college surveyed 1012 strains of MRSA collected from 14 cities in China, showed that the incidence of hVISA was between 13% and 16% \[[@j_med-2018-0071_ref_008]\]. In addition, our previous studies have shown that the four-year period (2007-2010) of hVISA prevalence is from 8.2% to 11.7% in Northeast China \[[@j_med-2018-0071_ref_007]\]. Cell wall thickening with structural abnormality is the most common feature of hVISA comparing with VSSA \[[@j_med-2018-0071_ref_009],[@j_med-2018-0071_ref_010]\]. Studies have shown that genetic changes also lead to low-level vancomycin resistance in *S. aureus*. *Spa* typing has emerged as an effective and rapid method for typing MRSA to moderate discrimination and exhibit high throughput inter-laboratory reproducibility \[[@j_med-2018-0071_ref_011]\]. Moreover, the two-component regulatory system of the accessory gene regulator (*agr*) has been linked to low-level vancomycin resistance in *S. aureus* as well \[[@j_med-2018-0071_ref_012]\].

Although *S. aureus* with reduced vancomycin susceptibility are clinically relevant, most of the data comes from patients with bacteremia. Therefore, four typical *S. aureus* strains from different clinical specimens were selected in this experiment, a VSSA from blood, a hVISA from sputum, a hVISA from blood, and a VISA from drainage liquid. To better clarify the phenotypic and molecular characteristics these strains were induced with vancomycin by an in vitro multi-step treatment.

2. Material and methods {#j_med-2018-0071_s_002}
=======================

2.1. Bacterial strains and culture conditions {#j_med-2018-0071_s_002_s_001}
---------------------------------------------

From 2007 to 2011, 757 strains of *S. aureus* were collected in two affiliated hospitals (2249 beds and 4818 beds respectively) of China Medical University and stored at -80°C in brain heart infusion (BHI) broth (Becton Dickinson, Sparks, MD, USA) containing 20% (v/v) glycerol. From each patient only one isolated strain was used in this study. The strains of *S. aureus* were identified with coagulase test using test tube and a VITEK 2 automation system (bioMerieux, France). Subsequently they were screened for hVISA or VISA with BHI agar containing 3 μg/ ml vancomycin (BHIA-3V) by PAP-AUC methods. Finally, 20 VSSA, 76 hVISA and 4 VISA strains were derivated. The MIC~VAN~ of strains was detected by antimicrobial susceptibility test. Based on the results of the test, four representative strains, with the number of 11, 143, 187 and 18 from different clinical specimens were selected for further experiments, and their MIC~VAN~s were 1 μg/ml, 1 μg/ml, 2 μg/ml, and 4 μg/ml, respectively.

2.2. Stepwise selection of vancomycin-resistant strains {#j_med-2018-0071_s_002_s_002}
-------------------------------------------------------

In order to select vancomycin-resistant strains, the clinical parental strains were subjected to a stepwise selection in the presence of vancomycin \[[@j_med-2018-0071_ref_013]\]. About 100 μl of 10^5^ colony-forming unit (CFU)/ml bacterial suspension cultured in BHI medium harboring 1/2 MIC vancomycin was plated on brain heart infusion agar (BHIA) plate which was supplemented with 4% sodium chloride and 1 MIC vancomycin. These strains were then plated onto BHIA plates with the vancomycin concentration of 1 μg/ml which was higher than 1 MIC. This selection procedure was repeated, and during each round of selection the used vancomycin concentration increased 1 μg/ml than that of last time until no further colonies could be isolated. [Figure 1](#j_med-2018-0071_fig_001){ref-type="fig"} shows the induction process of four parental strains. The total selection time for strain 11, 143, 187, and 18 was 45 days, 55 days, 60 days, and 60 days respectively. Therefore, the obtained derivative strains were named 11\*45d, 143\*55d, 187\*60d, and 18\*60d correspondingly. All strains were validated for their isogenicity by PFGE and stocked in 20% glycerol at -80°C.

![The induction process of four parental strains 11, 143, 187 and 18 with an initial vacomycin concentration of 1 μg/ml, 1 μg/ml, 2 μg/ml and 4 μg/ml respectively. Each round of selection lasted for 5 days with an increase of 1 μg/ml vancomycin concentration repeatedly.](med-13-475-g001){#j_med-2018-0071_fig_001}

2.3. PFGE {#j_med-2018-0071_s_002_s_003}
---------

PFGE was carried out as described previously \[[@j_med-2018-0071_ref_014]\]. Chromosomal DNAs of the parental and derivated strains were digested with SmaI and separated using a Gene Path system (CHEF-DR, PULS WAVE.760; Bio-Rad, Hercules, USA) according to the manufacturer's instructions, and a 48.5 kb ladder was used as the DNA size marker (Bio-Rad). Electrophoresis was performed for 22 h with an initial pulse time of 5 s and final pulse time of 40 s.

2.4. Antimicrobial susceptibility test {#j_med-2018-0071_s_002_s_004}
--------------------------------------

The MIC~VAN~ of strains were detected by trace cation-supplemented Mueller-Hinton broth (Oxoid) dilution method which was recommended by the guidelines of the Clinical And Laboratory Standards Institute (CLSI) \[[@j_med-2018-0071_ref_015]\]. And the MIC~VAN~ assays was determined both by the parental strain and the derivated strain. In general, MH medium was the only medium used in antimicrobial susceptibility test. However to simulate different growth environment, BHI media was used together with MH media in this study \[[@j_med-2018-0071_ref_016],[@j_med-2018-0071_ref_017]\]. Vancomycin was obtained from Sigma Chemical, St. Louis, MO, USA.

2.5. PAP-AUC test {#j_med-2018-0071_s_002_s_005}
-----------------

The vancomycin-resistant subpopulations of both parental and derivated strains were measured by PAP-AUC test \[[@j_med-2018-0071_ref_018]\]. In brief, after overnight growth in BHI broth, 50 μl bacterial suspension of seed culture was transferred into 4 ml pre-warmed BHI broth and incubated at 37°C, 200 rpm shaking speed. The new culture was cultivated in same growth condition to a status of approximately OD~600~ 0.7, and diluted with BHI media to OD~600~ 0.3 (approx. 10^8^ CFU/ ml). The cultures were then diluted in saline to 10^--7^ CFU/ ml and spreaded onto BHIA plates containing 0, 1, 2, 3, 4, 5, 6, 8, 10 or 12 mg/ L of vancomycin respectively. Colonies were counted after 48 h incubation at 37°C and the viable count was plotted against vancomycin concentration using GraphPad Prism 5 (GraphPad; San Diego, CA, USA). The plotted data was then used to calculate AUC. To distinguish VISA, hVISA and vancomycin-susceptible MRSA, a ratio that the AUC of tested MRSA divided by the corresponding AUC of Mu 3 was calculated. The criteria used for detection of hVISAs were the AUC ratio of 0.9. In this test, the hVISA strain Mu3 (ATCC 700698) and VISA strain Mu50 (ATCC 700699) were used as positive controls while the VSSA strain ATCC29213 was used as a negative control. The result of each experiment was adopted only when the positive and negative controls were confirmed.

2.6. Molecular typing {#j_med-2018-0071_s_002_s_006}
---------------------

A standard protocol for DNA extraction was used to provide template in PCR experiments \[[@j_med-2018-0071_ref_019]\]. The *spa* gene encoding protein A of *S. aureus* was amplified and the DNA product was sequenced by Beijing Genomics Institute (Beijing, China) \[[@j_med-2018-0071_ref_020]\]. RIDOM Staph-Type software (Ridom GmbH,Germany) was used to analyze the *spa* sequence and define the *spa* type. In multiplex PCR, 5 primers were used to analyze the *agr* type \[[@j_med-2018-0071_ref_021]\]. The primers used in this experiments are summarized in [Table 1](#j_med-2018-0071_tab_001){ref-type="table"}.

###### 

Primers used in molecular typing experiments

  Fragment   Primer Orientation   Sequence                               
  ---------- -------------------- -------------------------------------- ----
             Forward              5 '-TAAAGACGATCCTTCGGTGAGC-3'          
  spa                                                                    
             Reverse              5'-CAGCAGTAGTGCCGTTTGCTT-3'            
             Sa                   5'-ATGCACATGGTGCACATGC-3'              
             1Sa                  5 '-GTCACAAGTACTATAAGCTGCGAT-3'        
  agr        2Sa                  5 '-TATTACTAATTGAAAAGTGCCATAGC-3'      
             3Sa                  5 '-GTAATGTAATAGCTTGTATAATAATACCCAG-   3'
             4Sa                  5 '-CGATAATGCCGTAATACCCG-3'            

2.7. Transmission electron microscopy {#j_med-2018-0071_s_002_s_007}
-------------------------------------

The *S. aureus* cells in logarithmic phase were fixed in 2.5% glutaraldehyde of 0.1 M PBS (pH 7.4) for 1 h, and treated with 1% osmium tetroxide at 4°C for 1 h. These cells were then dehydrated with different graded concentrations of ethanol, and embeded in Epon812. Ultra-thin sections were stained with uranium acetate and lead citrate, then examined with JEM-1200EX transmission electron microscope (Jeol, Japan). The cell wall thickness was evaluated by photographic images at a magnification of 30,000 times and measured as Cui described previously \[[@j_med-2018-0071_ref_022]\]. Ten cells of each strain were measured in this study.

2.8. δ-hemolysin expression {#j_med-2018-0071_s_002_s_008}
---------------------------

RN4220 is a standard strain of *S.aureus* which can only produce β-hemolysin on sheep blood agar plate. While β-hemolysin production in RN4220 could be enhanced by δ-hemolysin, the expression tests were carried out on sheep blood plate. One linear *S.aureus* RN4220 cells was firstly streaked out on the plate, and then the parental and derivated strains were cross-streaked perpendicularly to RN4220 on sheep blood agar plate to detect the δ-hemolysin they produced \[[@j_med-2018-0071_ref_023]\]. The VSSA strain ATCC29213 was used as a positive control and the hVISA strain Mu3 (ATCC 700698) and VISA strain Mu50 (ATCC 700699) were used as negative controls respectively.

2.9. Autolysis assay {#j_med-2018-0071_s_002_s_009}
--------------------

For autolysis assay, *S.aureus* was inoculated in BHI media at 37°C to make a seed culture. After overnight growth, 200 μl bacterial suspension was added to 20 ml BHI broth and incubated at same culture condition until OD~600~ was raised to 0.8. Then the culture was chilled rapidly, washed in ice-cold PBS and resuspended in 50 mM glycine-0.01%Triton X-100 buffer (pH 8.0) to an OD~600~ of about 1.0. Samples were incubated with gentle shaking, and the OD~600~ was measured hourly using a U-2900 double beam spectrophotometer (Hitachi) \[[@j_med-2018-0071_ref_024]\]. Each assay was performed in triplicates respectively.

2.10. Biofilm assay {#j_med-2018-0071_s_002_s_010}
-------------------

The ability of strains to adhere to a polystyrene microtiter plate was assessed as described before \[[@j_med-2018-0071_ref_025]\]. After overnight growth in 4 ml BHI broth, the *S.aureus* culture was diluted to a1:100 ratio in 4 ml fresh BHI broth, and grew to a OD~600~ of about 0.3. Then the newly obtained culture was diluted again to the concentration of about 10^5^ CFU/ml, and 200 μl of which was added to each well of the 96-well polystyrene microtiter plate (Greiner bio-one), with eight replicates per experiment. The plate was incubated at 37°C with shaking for 24 h. Unbound cells were removed carefully by inversing the plate and tapping on an absorbent paper. The adherent cells were stained with 200 μl of 0.1% crystal violet, and the excess dye was removed by rinsing three times with 250 μl PBS. The solvent was then removed from the cells and the crystal violet was dissolved by adding 200 μl of ethanol-acetone (80:20, wt/wt). The UV-Vis absorbance of the sample was measured at 578 nm with a VarioskanTM flash multimode reader (Termo Fisher). Each assay was performed in triplicates respectively.

2.11. Quantitative real-time PCR for gene expression {#j_med-2018-0071_s_002_s_011}
----------------------------------------------------

Total RNA from each sample in early-exponential phase was extracted using the RNAiso Plus Kit (Takara) following the manufacturer's instructions \[[@j_med-2018-0071_ref_026]\]. To remove DNA contamination, each RNA sample was digested with DNase I using standard DNase protocol (Takara), and cDNA was reverse-transcripted using PrimeScript® RT reagent Kit with gDNA Eraser (Takara). Six genes (16S ribosomal RNA, RNAIII, icaA, icaR, lytM and atl) were monitored by qPCR reactions, which were performed with 2 μl of cDNA, 10μl of SYBR® Premix Ex TaqTM II (Takara), 0.8 μl of forward primer (0.4 μM), 0.8 μl of reverse primer (0.4 μM), and RNase free water added to a final volume of 20 μl at last. Reactions were carried out with an ABI 7500 Real-Time PCR system (Applied Biosystems). The primers used in the experiments are summarized in [Table 2](#j_med-2018-0071_tab_002){ref-type="table"}. The transcription of each gene was normalized on the basis of 16S rRNA level. Each assay was performed in triplicate and repeated twice.

###### 

Primers used in quantitative real-time PCR experiments

  Fragment   Primer Orientation   Sequence
  ---------- -------------------- -----------------------------
             Forward              5'-TTCACTGTGTCGATAATCCA-3'
  RNAIII                          
             Reverse              5'-TGATTTCAATGGCACAAGAT-3'
             Forward              5'-CTTGCTGGCGCAGTCAATAC-3'
  icaA                            
             Reverse              5'-GCGTTGCTTCCAAAGACCTC-3'
             Forward              5'-GGAGTATGACGGTACAACAC-3'
  icaR                            
             Reverse              5'-CGCCTGAGGAATTATCTGGA-3'
             Forward              5'-ATACATTCGTAGATGCTCAAG-3'
  lytM                            
             Reverse              5'-ATCATGGCTGTTATACGCTTG-3'
             Forward              5'-GGCAAGCGTTATCCGGAATT-3'
  atl                             
             Reverse              5'-GTTTCCAATGACCCTCCACG-3'
             Forward              5'-GGCAAGCGTTATCCGGAATT-3'
  16SrRNA                         
             Reverse              5'-GTTTCCAATGACCCTCCACG-3'

2.12. Statistical analysis {#j_med-2018-0071_s_002_s_012}
--------------------------

Statistical analyses were performed using SPSS version 16.0 (SPSS Inc., USA). Statistical significance was determined with the unpaired Student's t-test. P-value less than 0.05 was considered statistically significant.

**Ethical approval**: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors\' institutional review board or equivalent committee.

**Informed consent**: Informed consent has been obtained from all individuals included in this study.

3. Results {#j_med-2018-0071_s_003}
==========

3.1. Stepwise selection of vancomycin-resistant strains {#j_med-2018-0071_s_003_s_001}
-------------------------------------------------------

During the induction process ([Fig.1](#j_med-2018-0071_fig_001){ref-type="fig"}), it was interesting to see that the survival of strain 11 became harder and harder when the concentration of vancomycin increased gradually, and fewer vancomycin-resistant subgroups emerged compared to other three strains. After 45 days' continuous induction of vancomycin in vitro, strain 11 could eventually grow on BHIA plate with vancomycin concentration as high as 8 μg/ml. Before the concentration of vancomycin in BHIA plate was increased to 4 μg/ml, a few subgroups of strain 143 could survive, but after repeating the induction steps in the same vancomycin concentration for multiple times, vancomycin-resistant subgroups increased abundantly. Strain 143 could eventually grow on BHIA plate with vancomycin concentration as high as 11 μg/ml by increasing the vancomycin concentration continuously for 55 days. The induction processes of strain 187 and strain 18 were relatively smooth compared with strains 11 and 143. The final tolerated vancomycin concentration of strain 187 and strain 18 was 14 μg/ml and 16 μg/ml after 60 days' induction respectively.

3.2. PFGE results {#j_med-2018-0071_s_003_s_002}
-----------------

Strains were considered identical in genotype when their PFGE patterns contained the same number and sizes of fragments. PFGE patterns with less than four band differences from an existing genotype were defined as its sub-types \[[@j_med-2018-0071_ref_021]\]. The PFGE results ([Fig.2](#j_med-2018-0071_fig_002){ref-type="fig"}) showed that the electro-phoretic bands of all the derivated strains were consistent with their parental strains, which indicated that the derivative strains were homologous to their parental strains. The electrophoretic band of each derivated strain was not identical compared with each other, which illustrated the different clinical origin of the four derivated strains.

![The electrophoretic bands of parental and derivated strains. DNA marker is Bio-Rad CHEF DNA size marker (\#170-3635).](med-13-475-g002){#j_med-2018-0071_fig_002}

3.3. Antimicrobial susceptibility results {#j_med-2018-0071_s_003_s_003}
-----------------------------------------

It was interesting to see that the MIC~VAN~s of all strains in BHI medium were higher than that in MH medium ([Table 3](#j_med-2018-0071_tab_003){ref-type="table"}). The parental strains 11 and 143 had the same MIC~VAN~ of 1 μg/ml in MH medium and 2 μg/ml in BHI medium, their corresponding derivated strains 11\*45d and 143\*55d also displayed the same MIC~VAN~ of 4 μg/ml in MH medium and 8 μg/ml in BHI medium respectively. The MIC~VAN~ of parental strain 187 was 2 μg/ml in MH medium and 6 μg/ml in BHI medium, while the MIC~VAN~ of 187\*60d was 6 μg/ml in MH medium and 12 μg/ml in BHI medium. The MIC~VAN~ of 18 was 4 μg/ml in MH medium and 6 μg/ml in BHI medium, while the MIC~VAN~ of 18\*60d was 6 μg/ml in MH medium and 16 μg/ml in BHI medium.

###### 

The MICvan and molecular type of four pairs of strains determined by CLSI broth microdilution method with BHI and MH medium **Vancomycin MIC (μg/ml) Molecular type**

  Strains    Source      Oxacillin resistance   Glycopeptide phenotype   BHI   MH   spa type   agr group
  ---------- ----------- ---------------------- ------------------------ ----- ---- ---------- -----------
  11         blood       MSSA                   VSSA                     2     1    t3932      I
  11\*45d                                                                8     4               
  143        sputum      MRSA                   hVISA                    2     1    t570       II
  143\*55d                                                               8     4               
  187        secretion   MRSA                   hVISA                    6     2    t570       II
  187\*60d                                                               12    6               
  18         drainage    MRSA                   VISA                     6     4    t570       II
  18\*60d                                                                16    6               

3.4. Molecular typing {#j_med-2018-0071_s_003_s_004}
---------------------

Sequence analysis revealed that the *spa* and *agr* genes of parental strains 143, 187, 18 and their derivated strains belonged to *spa* type t570 and *agr* group II respectively while strain 11 and 11\*45d had the same genotype of *spa* type t3932 and *agr* group I ([Table 1](#j_med-2018-0071_tab_001){ref-type="table"}).

3.5. Transmission electron microscopy {#j_med-2018-0071_s_003_s_005}
-------------------------------------

As expected, the cell wall of derivated strains was much more thicker than the corresponding parental strains ([Fig.3](#j_med-2018-0071_fig_003){ref-type="fig"}). The cell wall thickness in nm of parental strains 11, 143, 187, and 18 were 20.34±5.46, 25.63±3.78, 27.21±4.43, and 28.89±6.12 respectively, while the number of their corresponding derivated strain 11\*45d, 143\*55d, 187\*60d, and 18\*60d had cell wall thickness 40.67±4.52 (p\<0.05), 45.92±5.81 (p\<0.05), 63.54±2.37 (p\<0.01), and 78.62±7.98 (p\<0.01) respectively.

![The cell wall thickness (nm) of representative parental strains and their vancomycin-resistant derivated strains. Microscope magnification: ×30,000](med-13-475-g003){#j_med-2018-0071_fig_003}

3.6. PAP-AUC results {#j_med-2018-0071_s_003_s_006}
--------------------

Compared with parental strains, the numbers of vancomycin-resistant subgroups of derivated strains increased significantly ([Fig.4](#j_med-2018-0071_fig_004){ref-type="fig"}). Meanwhile their resistance to vancomycin was significantly enhanced. The parental strain 11 was classified to be VSSA because of the ratio AUC11/AUCMu3 \<0.9, while the corresponding derivated strain 11\*45d was classified to be VISA because of the ratio value of AUC11\*45d/AUCMu3\>1.3. The parental strain 143 was classified to be hVISA because the ratio value ranges from 0.9≤ AUC143/AUCMu3 ≤1.3, while the corresponding derivated strain 143\*55d was VISA. Similarly, the parental strain 187 and the derivated strain 187\*60d were hVISA and VISA respectively while the both the parental strain 18 and the derivated strain 18\*60d were VISA.

![Population analysis of four pairs of parental strains and derivated strains. The hVISA strain Mu3 (ATCC 700698) and VISA strain Mu50 (ATCC 700699) were used as positive controls. The VSSA strain ATCC29213 was used as a negative control.](med-13-475-g004){#j_med-2018-0071_fig_004}

3.7. Autolytic assay {#j_med-2018-0071_s_003_s_007}
--------------------

Compared with the parental strains, the autolysis activity of all derivated vancomycin-resistant VISA strains were decreased, but the reduction level of autolysis was different ([Fig.5](#j_med-2018-0071_fig_005){ref-type="fig"}). The autolysis level of strain 11\*45d, 143\*55d and 187\*60d was between that of standard hVISA strain Mu3 and Mu50, close to that of Mu50 and higher than that of Mu50 respectively. However, the autolysis level of parental VISA strain 18 was less than that of Mu50 while its derivated strain 18\*60d did not decreased significantly but increased to be a little higher that that of Mu50.

![Autolytic assay results of four pairs of parental strains and derivated strains. The results which described as the mean OD values were done in triplicates.](med-13-475-g005){#j_med-2018-0071_fig_005}

3.8. δ-hemolysin expression {#j_med-2018-0071_s_003_s_008}
---------------------------

[Fig. 6](#j_med-2018-0071_fig_006){ref-type="fig"} shows the δ-hemolysin production of all the tested strains. Similar to positive control (strain ATCC29213), there was an enhanced zone of hemolysis at the border of VSSA strain 11 and quality control strain RN4220. However, there was no enhanced hemolysis zone at the borders of vancomycin-resistant parental or derivated strains with strain RN4220, just like the results of negative controls (hVISA strain Mu3 and VISA strain Mu50).

![The δ-hemolysin production in parental and derivated strains. β-hemolysin producing strain RN4220 is streaked vertically and the test strains are streaked horizontally. The VSSA strain ATCC29213 was used as a positive control, the hVISA strain Mu3 (ATCC 700698) and VISA strain Mu50 (ATCC 700699) were used as negative controls.](med-13-475-g006){#j_med-2018-0071_fig_006}

3.9. Biofilm assay {#j_med-2018-0071_s_003_s_009}
------------------

The results of biofilm assay revealed a reduction in adhesive ability for all derivated vancomycin-resistant strains compared to that of the parental strains (p\<0.05). Moreover, the biofilm formation ability of parental VISA strain 18, hVISA strains 143 and 187 reduced significantly compared with VSSA strain 11 ([Fig.7](#j_med-2018-0071_fig_007){ref-type="fig"}).

![The biofilm formation of four pairs of parental and derivated strains (\*P\<0.05). The results were done in triplicates.](med-13-475-g007){#j_med-2018-0071_fig_007}

3.10. Quantitative real-time PCR results {#j_med-2018-0071_s_003_s_010}
----------------------------------------

The results of quantitative real-time PCR showed that the relative expression levels of *atl* gene which related to autolysis for the derivated strains 11\*45d, 143\*55d, 187\*60d, and 18\*60d were 0.21, 0.77, 0.29, and 0.89 times fold changes compare with their corresponding parental strains, and that levels of another autolysis related gene *lytM* for the four derivated strains were 0.41, 0.78, 0.62, and 0.93 times respectively. The relative expressions of *icaA* gene which related to the biofilm formation were 0.35, 0.64, 0.19, and 0.72 times, while the relative expressions of another that related gene *icaR* were 0.36, 0.53, 0.56, and 0.67 times respectively. The relative expressions of RNAIII gene, an effect factor in *agr* regulating system, were 0.49, 0.01, 0.03, and 0.83 times respectively in the derivated strains compared with their parental strains ([Fig.8](#j_med-2018-0071_fig_008){ref-type="fig"}).

![The relative gene expression (A. *Atl*, B. *lytM*, C. *icaA*, D. *icaR*, E. RNAIII) of derivated strains compared to that of their parental strains (\*P\<0.05, \*\*P\<0.01).](med-13-475-g008){#j_med-2018-0071_fig_008}

4. Discussion {#j_med-2018-0071_s_004}
=============

The vancomycin's mode of action is well known as the inhibition of bacteria cell wall biosynthesis by binding with the terminal D-alanyl-D-alanine moieties via hydrogen bond interactions formations \[[@j_med-2018-0071_ref_027]\]. The interaction of the five hydrogen bonds form the binding network in the vancomycin dimer conformation \[[@j_med-2018-0071_ref_028],[@j_med-2018-0071_ref_029]\]. Since the first VISA and hVlSA were reported in Japan \[[@j_med-2018-0071_ref_030],[@j_med-2018-0071_ref_031]\], the *S. aureus* with reduced vancomycin susceptibility have attracted more and more attention from scientists. The reported vancomycin resistance mechanism is the induced alteration of terminal amino acid residues from D-alanyl-D-ala-nine to a D-alanyl-D-lactate variation which results in the loss of one hydrogen-bonding interaction \[[@j_med-2018-0071_ref_032]\]. The evidence about phenotypic and molecular characterization of vancomycin-resistant *S. aureus* mainly come from clinical cases \[[@j_med-2018-0071_ref_033], [@j_med-2018-0071_ref_034], [@j_med-2018-0071_ref_035], [@j_med-2018-0071_ref_036]\], however the complex environment of the human body will affect the exploration of relationship between VSSA and vancomycin-resistant hVISA or VISA. In this study, the in vitro stepwise selection of vancomycin-resistant strain was used to simulate the process of clinical inducing treatment. It is interesting that none of the derivated strains developed into VRSA in highest vancomycin concentration during up to 60 days of persistent vancomycin stimulation. PFGE analysis and molecular typing suggested that the parental strains were genetically homologous to their corresponding derivated strains.

We also found that the MIC~van~s of *S. aureus* strains in BHI medium were higher than that in MH medium. These results indicate that the vancomycin resistance level of *S. aureus* isolates is closely related to the nutritional status of environment. BHI medium which can provide better nutrition for *S. aureus* is similar to the environment of human body, while MH medium which just like the external environment does not provide enough nutrition to support bacteria growth. This could be the reason why the derivated strains of *S. aureus* can resist high concentration of vancomycin in BHI culture medium but the MIC~van~s detected with MH media can not rise to VRSA level. It is also worth to mention that BHI medium was used to detect the differences of vancomycin resistance between parental and derivated strains, which displayed similar results in PAP-AUC test. Under the same vancomycin concentration, the quantity of vancomycin-resistant subgroups of the derivated strains was close to or more than that of the standard VISA strain Mu50, but none of the strains developed into VRSA. A significant increase in the cell wall thickness demonstrated in all hVISA and VISA strains was consistent with previous reports \[[@j_med-2018-0071_ref_010],[@j_med-2018-0071_ref_023]\], from which the cell wall thickness was confirmed positively to be associated with the degree of vancomycin resistance ([Fig. 3](#j_med-2018-0071_fig_003){ref-type="fig"}).

The results of molecular typing revealed that the parental hVISA or VISA strains 143, 187, 18 and their derivated strains belonged to *spa* type t570 and *agr* group II, while the parental VSSA strain 11 and its derivated strain belonged to the same *spa* type t3932 and *agr* group I ([Table 1](#j_med-2018-0071_tab_001){ref-type="table"}). These findings are consistent with the previous reports, in which the *agr* type II strains and loss of *agr* function are associated with VISA \[[@j_med-2018-0071_ref_012]\].

δ-hemolysin production was another function for *agr* operon \[[@j_med-2018-0071_ref_037]\]. The *agr* operon consists two divergent promoters P2 and P3, and the expression of P3 controlled operon produces the *agr* effector molecule RNAIII which is responsible for post-transcriptional regulation of multiple virulence factors, such as α-haemolysin and δ-haemolysin (encoded within the RNAIII transcript) \[[@j_med-2018-0071_ref_038],[@j_med-2018-0071_ref_039]\]. The lack of δ-hemolysin expression was most likely due to the loss of *agr* ^\[[@j_med-2018-0071_ref_012]\]^. In this study the only clinical parental VSSA strain 11 produced strong δ-hemolysin, however, all the other hVISA and VISA strains did not produce δ-hemolysin. Furthermore, the expressions of RNAIII in the derivated strains significantly reduced compared with their corresponding clinical parental strains ([Fig.8](#j_med-2018-0071_fig_007){ref-type="fig"}). In these cases, we infer that hVISA and VISA can produce less toxin than VSSA due to the lowly expressed regulatory genes for producing the main toxin δ-haemolysin.

In addition, the loss or defection of *agr* function is also associated with autolysis level of *S. aureus* \[[@j_med-2018-0071_ref_023],[@j_med-2018-0071_ref_025]\]. Reduced autolytic activity has already been established as a common symptom to the hVISA and VISA phenotype \[[@j_med-2018-0071_ref_025]\]. In our study, autolytic activity reduction was observed in all of the four VISA derivated strains, however the degree of autolysis reduction was different in every strain pair ([Fig.5](#j_med-2018-0071_fig_005){ref-type="fig"}). Autolytic activity is generally affected by cell wall composition, autolysin enzymatic activities, autolysin gene transcription and post translational processing of autolysins \[[@j_med-2018-0071_ref_040]\]. Some studies reported that VISA emerged to hVISA when VISA acquired a reduced autolysis activity caused by a down-regulation of autolysin genes (*atl*/*lytM*) \[[@j_med-2018-0071_ref_041]\]. We thus examined the expression of *atl* and *lytM* genes. The expression levels of these two genes reduced in all derivated strains.

Loss of *agr* function could also have significant effects on exoprotein and adhesion expression which could potentially promote biofilm formation \[[@j_med-2018-0071_ref_012],[@j_med-2018-0071_ref_023]\]. Compared with parental VSSA, the biofilm formation ability of derivated hVISA or VISA decreased remarkably \[[@j_med-2018-0071_ref_025]\]. One of the major constituents of staphylococcal biofilms is poly N-acetyl glucosamine (PIA/PANG) which is synthesized by icaADBC complex \[[@j_med-2018-0071_ref_042]\]. According to our results, the biofilm formation and relative expression of *icaA* gene in all derivated strains were reduced while the relative expression of *icaR* was also decreased in each group \[[@j_med-2018-0071_ref_043]\]. Some reports \[[@j_med-2018-0071_ref_042], [@j_med-2018-0071_ref_043], [@j_med-2018-0071_ref_044]\] demonstrated that *icaR* was a negative regulator for icaADBC expression. Other regulatory factors, such as *sarA*, *sigmaB*, *rbf*, and *ccpA* etcs were also reported to affect the *ica* gene expression as well as the PIA/PANG production. It is obvious that the regulation is extremely complex and multi-factorial which is similar to the consequence of previous reports \[7, [@j_med-2018-0071_ref_025]\].

5. Conclusion {#j_med-2018-0071_s_005}
=============

This study revealed that the clinical isolates VSSA, hVISA and VISA could be derivated into high vancomycin-resistant VISA but difficult to develop into VRSA in vitro. Mean-while, the changes of phenotype and regulated genes expression were inversely proportional to the MICvan value in derivated strains. In addition, the results of this study also showed that hVISA and VISA could gradually adapt to the living pressure changes via the continuous elevation in vancomycin concentration, and grow eventually with relatively higher vancomycin concentration. These findings provide comprehensive information that build up the detailed process of vancomycin resistance evolution and pave the way for keeping vancomycin susceptibility in further clinical applications.

We thank Professors Keiiti Hiramatsu and Teruyo Ito (Juntendo University) for providing vancomycin-resistant S. Aureus Mu50 and heterogeneous vancomycin-resistant S. Aureus Mu3 as population analysis standards.

**Authors' contribution**:

JX, LP and XM participated in the design of the study; JH, YT, YY and DS performed experiments; JX, LP and XM analyzed data; JX wrote the manuscript; JX and XM reviewed the manuscript.

**Source of support**

This work was supported by the National Natural Science Foundation of China (No. 30972520).

**Conflict of interest**

Authors state no conflict of interest.

[^1]: \# These authors contributed equally to this work.
